mRNA |
Zebularine |
CTRPv2 |
pan-cancer |
AAC |
-0.01 |
0.8 |
mRNA |
BRD-K34099515 |
CTRPv2 |
pan-cancer |
AAC |
0.023 |
0.8 |
mRNA |
PD-0325901 |
CCLE |
pan-cancer |
AAC |
0.012 |
0.8 |
mRNA |
navitoclax:sorafenib (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.01 |
0.8 |
mRNA |
CIL70 |
CTRPv2 |
pan-cancer |
AAC |
-0.014 |
0.8 |
mRNA |
GSK4112 |
CTRPv2 |
pan-cancer |
AAC |
0.011 |
0.8 |
mRNA |
ZSTK474 |
CTRPv2 |
pan-cancer |
AAC |
0.011 |
0.8 |
mRNA |
selumetinib:PLX-4032 (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.01 |
0.8 |
mRNA |
BRD-A71883111 |
CTRPv2 |
pan-cancer |
AAC |
-0.01 |
0.8 |
mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.009 |
0.8 |